The clinical success rate was 90.7% with a significant improvement in West Haven scores among 33 patients and mild improvement in six patients. The researchers noted that partial occlusion was due to multiple large shunts. The technical success rate was 100% with complete shunt occlusion in 37 patients and partial occlusion in six patients. Lee and colleagues reviewed the records of 43 patients who received CARTO for refractory overt hepatic encephalopathy with spontaneous portosystemic shunts (SPSSs). “The indwelling balloon has been shown to increase the length of stay because the patient needs to be continuously monitored, while the balloon is in place.” “Without the indwelling balloon, CARTO can be performed as an outpatient procedure in many cases or as an inpatient procedure with a shorter length of stay or lower level of care,” Edward Wolfgang Lee, MD, PhD, from the University of California Los Angeles Medical Center, and colleagues wrote. The CARTO procedure is a modified form of balloon-occluded retrograde transvenous obliteration (BRTO) that involves the use of coils and Gelfoam (Pfizer) instead of indwelling balloons and sclerosing agents.
![coil assisted retrograde transvenous obliteration coil assisted retrograde transvenous obliteration](https://f6publishing.blob.core.windows.net/1763c7c9-a45c-452d-80cf-3c8b80281e6e/WJR-4-121-g002.jpg)
![coil assisted retrograde transvenous obliteration coil assisted retrograde transvenous obliteration](https://i1.rgstatic.net/ii/publication/280582165/figure/fig3/AS:617256874676226@1524176915671/Vascular-anatomy-of-gastric-varices-Origin-and-drainage_Q320.jpg)
If you continue to have this issue please contact to HealioĬoil-assisted retrograde transvenous obliteration was safe and effective in treating patients with refractory overt hepatic encephalopathy caused by spontaneous portosystemic shunts, according to recently published data.